Company Overview
| Stock Name | Microport |
|---|---|
| Stock Code | 00853 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事醫療器械之開發、制造及銷售業務。 |
| Listing Date | 2010-09-24 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市張江高科技園區張東路1601號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.microport.com.cn |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 6.10 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 770,857,000 |
Stock Connect Inclusion Analysis
| HK Market Cap | --- |
|---|---|
| Analysis Result | Already included in Stock Connect (both) |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 8.29 |
|---|---|
| First Day Open | HK$ 7.25 |
| First Day Change | 35.90% |
| First Day Volume | 254831000.0 |
| First Day Turnover | 1953430000.0 |
| Use of Proceeds | 1、約50%或714.1百萬港元,用于擴大本集團的產品系列;
2、約25%或357.1百萬港元,用于擴充本集團的生產設施;
3、約20%或285.7百萬港元,用于擴大本集團在中國和世界各地;
4、約5%或71.4百萬港元,用于營運資金及為其他一般企業用途提供資金。 |
Underwriting Syndicate
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (2)
Joint Lead Managers (2)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 常兆華 | — |
| Company Secretary | 楊兆琳 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Otsuka Pharmaceutical Co.,Ltd.(20.99%);Maxwell Maxcare Science Foundation Limited(18.00%);Shanghai ZJ Hi-Tech Investment Corporation(12.15%);HHLR Advisors, Ltd.(8.42%);HHLR Fund, L.P.(8.06%) |
|---|




